
BDPARP contains Olaparib 150 mg, a targeted therapy used to treat certain types of ovarian, breast, pancreatic, and prostate cancers. It works by blocking PARP enzymes to help stop cancer cells from repairing themselves.
| Generic Name | Olaparib |
| Manufacturer | BDR |
| Packing | 28 Tablets |
| Prescribed For | Ovarian, Breast, Pancreatic, Prostate cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.
Disclaimer
This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.